Joerg Czech
10Patents
2h-index
22Co-inventors
50Inventor score
Filing activity: Apr 10, 1996 → Dec 16, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6602688B1 | Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6008023A | Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7910576B2 | Pyrrole derivatives as P2Y12 antagonists | Chemistry; Metallurgy | 2 | Active |
| US7863269B2 | Imino-imidazo-pyridine derivatives having antithrombotic activity | Human Necessities | 1 | Active |
| US7892744B2 | Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders | Chemistry; Metallurgy | 0 | Active |
| US8552159B2 | Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy | Chemistry; Metallurgy | 0 | Active |
| US7364887B2 | Use of PAK inhibitor for the treatment of a joint disease | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8187828B2 | Use of PAK inhibitor for the treatment of a joint disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US8669266B2 | Quinoline-carboxamide derivatives as P2Y12 antagonists | Chemistry; Metallurgy | 0 | Active |
| US7314753B2 | Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.